Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Link
http://www.nature.com/articles/s41467-019-10979-3.pdf
Reference66 articles.
1. Coburn, S. B., Bray, F., Sherman, M. E. & Trabert, B. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int. J. Cancer 140, 2451–2460 (2017).
2. Tewari, K. S., Java, J. J., Eskander, R. N., Monk, B. J. & Burger, R. A. Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study. Ann. Oncol. 27, 114–121 (2016).
3. International Collaborative Ovarian Neoplasm, G. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet 360, 505–515 (2002).
4. Hung, C. F., Wu, T. C., Monie, A. & Roden, R. Antigen-specific immunotherapy of cervical and ovarian cancer. Immunol. Rev. 222, 43–69 (2008).
5. Alipour, S. et al. Specific immunotherapy in ovarian cancer: a systematic review. Immunotherapy 8, 1193–1204 (2016).
Cited by 191 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Janus kinase inhibitors modify the fatty acid profile of extracellular vesicles and modulate the immune response;Heliyon;2024-02
2. Tumor immune escape: extracellular vesicles roles and therapeutics application;Cell Communication and Signaling;2024-01-02
3. Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion;European Journal of Medicinal Chemistry;2024-01
4. An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer;International Journal of Molecular Sciences;2023-12-21
5. From Theory to Therapy: The Advancements of Extracellular Vesicles in Immunotherapy;Advanced Therapeutics;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3